Clinical Trials Logo

Clinical Trial Summary

the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group


Clinical Trial Description

the two groups will be taken standard therapy (hydrocortisone vial 100 mg and acetaminophen 1000 mg) 30 min before rituximab ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05648058
Study type Interventional
Source Ministry Of Health / Nineveh Health Directorate
Contact fakhraldin marwan
Phone 07817639470
Email drfakhralin@gmail.com
Status Not yet recruiting
Phase Phase 3
Start date December 20, 2022
Completion date November 20, 2023

See also
  Status Clinical Trial Phase
Completed NCT03130010 - The Effect of Nefopam on Catheter-related Bladder Discomfort N/A